Medicare Part D beneficiaries will see a 7.5% increase in costs in 2009.
According to the
Q&A: Factors Showing Tirzepatide is More Beneficial Than Semaglutide | ASHP Midyear
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.